GlassScriptPhysician profile
Laura Jane Evors
NPI 1750526463
$1,311.25
in general payments reported to CMS, 2019-2025
27 companies · $263 in 2025
The $263 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $233 · 2020: $53.87 · 2021: $113 · 2022: $82.26 · 2023: $228 · 2024: $338 · 2025: $263.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $829.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $216.29 | 2019-2025 | |
| Astellas Pharma US INC | $117.74 | 2019-2024 | Veozah, Myrbetriq |
| Biogen, INC. | $108.36 | 2024-2025 | Zurzuvae |
| Intuitive Surgical, INC. | $93.64 | 2024 | |
| Hologic Sales and Service, LLC | $88.23 | 2019-2025 | Fetal Fibronectin Enzyme Immunoassay |
| Sumitomo Pharma America, INC. | $81.67 | 2024-2025 | Myfembree, Gemtesa |
| Pfizer INC. | $75.26 | 2019-2024 | |
| Organon LLC | $60.62 | 2024-2025 | Jada System |
| Boston Scientific Corporation | $54.00 | 2023-2025 | Axonics, Upsylon |
| Optumhealth Care Solutions, LLC | $50.53 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Mayne Pharma Commercial LLC | $47.92 | 2023 | |
| Evofem Biosciences, INC. | $32.79 | 2021 | |
| Amag Pharmaceuticals, INC. | $25.77 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $23.96 | 2019 | |
| Therapeuticsmd, INC. | $23.03 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $22.00 | 2025 | Proclaim |
| Baxter Healthcare | $21.80 | 2024 | Perclot |
| Innovation Technologies INC | $21.69 | 2025 | Irrisept |
| Agile Therapeutics, INC. | $21.40 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $18.76 | 2024 | |
| Roche Diagnostics Corporation | $17.79 | 2019 | |
| Genzyme Corporation | $17.13 | 2023 | |
| Exact Sciences Corporation | $16.74 | 2023 | Cologuard Collection Kit |
| Coopersurgical, INC. | $15.74 | 2025 | Sos |
| Mylan Pharmaceuticals INC. | $15.72 | 2021 | |
| Allergan, INC. | $11.69 | 2019 | |
| Convatec INC. | $10.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laura Evors listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.